Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis

Aim Direct‐acting antivirals (DAAs) are currently available even for patients with decompensated cirrhosis. Reportedly, hepatic functional reserve improved in the short term after achievement of sustained virologic response (SVR). We aimed to clarify the outcomes after achievement of SVR in patients...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology research 2022-03, Vol.52 (3), p.235-246
Hauptverfasser:	Atsukawa, Masanori, Tsubota, Akihito, Kondo, Chisa, Toyoda, Hidenori, Nakamuta, Makoto, Takaguchi, Koichi, Watanabe, Tsunamasa, Hiraoka, Atsushi, Uojima, Haruki, Ishikawa, Toru, Iwasa, Motoh, Tada, Toshifumi, Nozaki, Akito, Chuma, Makoto, Fukunishi, Shinya, Asano, Toru, Ogawa, Chikara, Abe, Hiroshi, Kato, Keizo, Hotta, Naoki, Shima, Toshihide, Matsuura, Kentaro, Mikami, Shigeru, Tachi, Yoshihiko, Fujioka, Shinichi, Okubo, Hironao, Shimada, Noritomo, Tani, Joji, Morishita, Asahiro, Hidaka, Isao, Moriya, Akio, Tsuji, Kunihiko, Akahane, Takehiro, Okubo, Tomomi, Arai, Taeang, Kitamura, Michika, Morita, Kiyoshi, Kawata, Kazuhito, Tanaka, Yasuhito, Kumada, Takashi, Iwakiri, Katsuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	ALBI score Albumin Antiviral agents Bilirubin Child–Pugh class Cirrhosis decompensated liver cirrhosis direct‐acting antivirals HCV Liver Liver cirrhosis liver functional reserves Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!